Indian Bevacizumab Exporters: Complete Supplier Ranking with Market Share — 346 Manufacturers (2026) — TransData Nexus

Q: Who is the largest bevacizumab buyer importing from India?

JSC R-PHARM (RUSSIA) is the largest bevacizumab importer from India with a 39.8% market share and import value of $18.7M.

Q: How many bevacizumab buyers import from India?

There are 346 active bevacizumab buyers importing from India, with a combined import market of $46.9M across 1,408 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top bevacizumab buyers from India?

The top 5 bevacizumab buyers — JSC R-PHARM, JSC R PHARM, BIOCON BIOLOGICS UK LIMITED, XXOCOXXBIOXXGICXXUK XXMITXX, DR.REDDYS LABORATORIES SAS — together control 71.1% of total bevacizumab import value from India.

Suresh Sormare

Bevacizumab

India Pharmaceutical Trade Intelligence

$46.9M196 Suppliers100 CountriesHS 30021500

ExportsIndia → RUSSIA50.3%India → NETHERLANDS14.3%

ImportsSWITZERLAND → India$1.2B GERMANY → India$344.1M

#1 Buyer: JSC R-PHARM

Market Analysis: Top Importing Countries & Their Importers

1Russia

Russia emerges as the first largest importing country, achieving a total trade value of $23.6M through 66 shipments. This represents a market share of 50.3% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: Russia has a diverse importer base, with their top importers including:

• JSC R-PHARM - $18.7M (79.1% of country's total business)

• JSC R PHARM - $4.9M (20.8% of country's total business)

Key Insight: Russia demonstrates strong market positioning with an average shipment value of $357.6K, indicating premium pricing strategy compared to the market average of $33.3K.

Russia is a key market for Bevacizumab imports, representing 50.3% of total trade value.

Primary Market

Secondary Market

2Netherlands

Netherlands emerges as the second largest importing country, achieving a total trade value of $6.7M through 20 shipments. This represents a market share of 14.3% of the total market activity, demonstrating their significant presence in the industry.

Buyer Segment Analysis

TransData Nexus Bevacizumab buyer market intelligence

1Buyer Segment Analysis

The 346 buyers of Bevacizumab from India can be categorized into several segments:

1. Distributors: Entities that purchase Bevacizumab in bulk to supply to various healthcare providers.

*Example*: JSC R-PHARM (Russia), the top buyer with purchases totaling $18.66 million, likely operates as a distributor, supplying Bevacizumab across Russia.

2. Hospital Groups: Large healthcare networks procuring directly for patient treatment.

*Example*: DR. REDDY'S LABORATORIES SAS (Colombia), with combined purchases of approximately $3.53 million, may represent a hospital group or a pharmaceutical company supplying hospitals.

3. Retail Chains: Pharmacy chains purchasing for direct consumer sales.

*Example*: ZYDUS PHARMACEUTICALS MÉXICO S.A. DE C.V. (Mexico), with purchases of $1.66 million, likely operates within this segment.

4. Government Procurement: National health agencies or international organizations procuring for public health programs.

*Example*: SEAN DOMINICAN SRL (Dominican Republic), with purchases of $1.01 million, may be involved in government procurement.

Country-Specific Import Regulations

TransData Nexus Bevacizumab buyer market intelligence

1Country-Specific Import Regulations

Russia:

1Regulatory Authority: Ministry of Health of the Russian Federation.
2Import Registration Process: Requires submission of a registration dossier, including clinical trial data, to the Ministry of Health.
3Estimated Timeline: Approximately 12-18 months.
4Import Tariff/Duty: Pharmaceutical products under HS Code 30021500 are subject to a 5% import duty.

Netherlands:

1Regulatory Authority: Medicines Evaluation Board (MEB).
2

Demand Drivers & Market Opportunity

TransData Nexus Bevacizumab buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Bevacizumab in importing countries is driven by several factors:

1. Disease Prevalence: Bevacizumab is primarily used in the treatment of various cancers, including colorectal, lung, and renal cancers. The prevalence of these cancers in importing countries significantly influences demand.

2. Government Healthcare Programs: Many countries have national health programs that subsidize or fully cover the cost of essential medicines, including Bevacizumab, thereby increasing accessibility and demand.

3. Universal Health Coverage Expansion: Efforts to expand universal health coverage in countries like Colombia and Mexico have led to increased procurement of essential medicines to meet the needs of a larger insured population.

4. WHO Essential Medicines List Procurement: Bevacizumab's inclusion in the WHO Essential Medicines List encourages countries to prioritize its procurement to ensure availability for critical treatments.

5. Tender-Based Purchasing: Many governments and large healthcare providers utilize tender-based systems to procure medicines, ensuring competitive pricing and consistent supply.

With 346 buyers across 100 countries, the global demand for Bevacizumab from India reflects its critical role in oncology treatment and the effectiveness of India's pharmaceutical export strategies.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Bevacizumab Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest bevacizumab buyer importing from India?

Based on import volume and value, JSC R-PHARM (RUSSIA) leads with $18.7M in imports and a 39.8% market share — the highest of any single bevacizumab importer. JSC R PHARM (RUSSIA) and BIOCON BIOLOGICS UK LIMITED (NETHERLANDS) are the next largest buyers.

QHow many companies buy bevacizumab from India?

There are 346 active bevacizumab buyers importing from India, with a combined market of $46.9M across 1,408 shipments to 100 countries. The top 5 buyers hold 71.1% of total import value, while the remaining 341 buyers handle the other 28.9%.

QWhich countries import the most bevacizumab from India?

The top importing countries for bevacizumab from India are Russia (50.3%), Netherlands (14.3%), Colombia (7.9%), Mexico (3.6%), Venezuela (3.1%). These markets represent the largest demand centres for Indian pharmaceutical exports of bevacizumab, with buyers ranging from government procurement agencies to private pharmaceutical distributors.